GMT Data

Ascentage Pharma Group International (06855)

DirectorsAuditors
DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Bozilenko Marina S25-Nov-24INED
Chan Charmayne25-Feb-2501-Apr-26CoSec
26-Mar-26
Resignation
01-Apr-26AuRep
26-Mar-26
Resignation
Chen Yiqing29-Nov-2116-Nov-22CFO
Debra Yu26-Dec-25MbNC
Dr. David Sidransky02-Jan-25MbNC
02-Jan-25
Re-designated as the chairman of the Nomination Committee to comply with the listing rules of The Nasdaq Stock Market LLC.
Guo Edward Ming16-May-0931-Oct-21COO
Kmetz Raymond Jeffrey01-Feb-19Sen Mgr
Lippman Marc E02-Jan-25INED
Liu Qian01-Aug-1820-May-22NED
19-May-22
Due to his other business commitments which require more of his time and dedication
Lu Simon Dazhong06-Jul-18NED
Ren Wei13-Jun-19INED
02-Jan-25MbAC
02-Jan-25
Resigned to comply with the listing rules of The Nasdaq Stock Market LLC.
Sidransky David31-Mar-21INED
Tian Yuan06-Jul-1820-May-22NED
19-May-22
Due to his other business commitments which require more of his time and dedication
20-May-22MbCC
19-May-22
Due to his other business commitments which require more of his time and dedication
Wang Shaomeng17-Nov-17NED
Wong Johnny Cheung Ki30-Jul-1825-Feb-25CoSec
25-Feb-25
Resigned with no disagreement with the Board and no matters relating to his resignation that need to be brought to the attention of the shareholders of the Company and the Stock Exchange.
Yang Dajun17-Nov-17Ch, CEO, Co-Fdr
02-Jan-25ChNC, MbCC
02-Jan-25
Resigned to comply with the listing rules of The Nasdaq Stock Market LLC.
Ye Benjamin Changqing13-Jun-19INED
Yin Zheng13-Jun-1907-Jun-24INED
10-Jun-24
In order to devote more time to focus on his other business commitments
07-Jun-24ChCC, MbAC
10-Jun-24
In order to devote more time to focus on his other business commitments
Yu Debra Jiuyun25-Nov-24INED
Zhai Yifan16-Jul-13Sen Mgr
Zhang Su26-Aug-1901-Nov-21CFO
Zhao Qun06-Jul-1831-Mar-21NED
Zhu Gang01-Oct-20Sen Mgr